Case of Recovery from Late Chylothorax after Surgery for Esophageal Cancer following Administration of Octreotide Acetate and Injection of OK-432 into the Pleural Cavity

2006 ◽  
Vol 57 (1) ◽  
pp. 35-39 ◽  
Author(s):  
Shingo Tachibana ◽  
Yoshiaki Osaka ◽  
Sumito Hoshino ◽  
Masumi Yamazaki ◽  
Yu Takagi ◽  
...  
2014 ◽  
Vol 75 (6) ◽  
pp. 1547-1550 ◽  
Author(s):  
Toshiyasu OJIMA ◽  
Mikihito NAKAMORI ◽  
Masaki NAKAMURA ◽  
Makoto IWAHASHI ◽  
Masahiro KATSUDA ◽  
...  

2017 ◽  
Vol 42 (3) ◽  
pp. 749-757 ◽  
Author(s):  
Keijiro Sugimura ◽  
Hiroshi Miyata ◽  
Masaaki Motoori ◽  
Takeshi Omori ◽  
Yoshiyuki Fujiwara ◽  
...  

2016 ◽  
Vol 1 (13) ◽  
pp. 169-176
Author(s):  
Lisa M. Evangelista ◽  
James L. Coyle

Esophageal cancer is the sixth leading cause of death from cancer worldwide. Esophageal resection is the mainstay treatment for cancers of the esophagus. While curative, surgical resection may result in swallowing difficulties that require intervention from speech-language pathologists (SLPs). Minimally invasive surgical procedures for esophageal resection have aimed to reduce morbidity and mortality associated with more invasive techniques. Both intra-operative and post-operative complications, regardless of the surgical approach, can result in dysphagia. This article will review the epidemiological impact of esophageal cancers, operative complications resulting in dysphagia, and clinical assessment and management of dysphagia pertinent to esophageal resection.


Sign in / Sign up

Export Citation Format

Share Document